Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits | InvestorPlace
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
